Skip to content

    Honasa Consumer

    HONASA
    Fast Moving Consumer Goods·22 May 2025
    Management Summary

    Honasa Consumer reported a strong Q4 FY25 with 13.3% revenue growth and 21.2% UVG, driven by strategic focus on Mamaearth's core categories and robust performance of younger brands. The company significantly expanded its direct distribution network and saw green shoots from its investment allocation changes. While FY25 profit was impacted by one-off corrections, management expressed confidence in future growth and margin improvement.

    Highlights

    8
    • Q4 revenue grew 13.3% YoY, indicating healthy double-digit growth.

    • UVG (Underlying Volume Growth) was robust at 21.2%, demonstrating strong consumer traction.

    • Gross profit improved year-over-year, contributing to overall financial health.

    • EBITDA remained stable compared to the previous quarter, despite strategic investments.

    • Generated INR74 crores of cash in Q4, reflecting efficient working capital management (negative 24 days).

    • Mamaearth's focus categories (70% of brand) showed positive double-digit growth in e-commerce and modern trade.

    • Younger brands grew over 30% YoY, with Derma Co achieving INR100 crores ARR in offline channels.

    • Direct distribution network expanded significantly to 102,000 outlets, up from 45,000-50,000.

    Concerns

    3
    • FY25 profit took a hit due to 'project Neev execution and corrections'.

    • Mamaearth's non-focus categories are declining, putting pressure on overall brand topline growth.

    • Younger brands require higher A&P spend due to lower awareness, impacting overall profitability in the short term.

    Key financials

    Metrics

    5

    Periods

    2

    Q4

    4
    • Revenue Growth
      13.3%
    • UVG Growth
      21.2%
    • Cash Generated
      ₹74 Cr
    • Working Capital Days
      -24 days

    FY25

    1
    • Revenue
      ₹2,067 Cr
      YoY+7.7%

    Capital allocation

    2
    high confidence
    CategoryHeadline
    M&A

    Cosmogenesis

    acquisition · integrated

    Liquidity

    Cash ₹74 crores

    Generated INR74 crores of cash in Q4, with negative 24 days working capital.

    Guidance & targets

    8
    CategoryTargetPriority
    Profitability
    EBITDA Improvement
    250 basis points
    High
    Profitability
    EBITDA Profile
    FY24 levels
    High
    Distribution
    GT Outlets
    150,000
    High
    Brand Strategy
    Mamaearth Focus Categories Contribution
    85% to 90%
    High
    Brand Strategy
    Mamaearth Focus Categories Growth
    double digits
    High
    Brand Strategy
    Younger Brands Growth
    30% plus
    High
    Brand Strategy
    Non-focus Categories Contribution
    15%
    High
    Category Growth
    Serum Category Growth
    30%
    High

    Mamaearth Overall Y-o-Y Growth

    next 1-2 quarters
    CurrentFocus categories positive double-digit, overall difficult to comment
    TargetPositive Y-o-Y growth for Mamaearth as a whole

    Why it matters

    Indicates the success of the strategic shift and overall brand health beyond specific categories.

    I wouldn't even want to sort of comment on that because the math is that these focus categories where we are putting in the effort, they did show the right kind of green shoots. And now it's only been sort of 2 to 3 months of execution of those strategies.

    How to verify

    key_financials.metrics[label='Mamaearth Revenue Growth']

    Risks & concerns

    3
    RiskSeverity

    Impact of 'Project Neev' execution and corrections on profit

    FY25 profit took a hit due to 'project Neev execution and corrections' and associated costs.Management acknowledged

    medium

    Declining non-focus categories impacting Mamaearth's overall topline growth

    The decline in non-focus categories puts pressure on Mamaearth's overall year-over-year topline growth.Analyst acknowledged

    medium

    Higher A&P spend for younger brands due to lower awareness

    Younger brands require higher advertising and promotion spend to build awareness, which can impact short-term profitability.Management acknowledged

    low

    Q&A highlights

    8

    “in Mamaearth, our entire focus is now on certain set of focus categories. In those focus categories, yes, our growth is positive, and it is in double digits in specific channels like e-commerce and modern trade.”

    Analyst is probing for overall brand recovery, but management focuses on specific categories, indicating overall brand might still be negative or flat.

    asked by Percy Panthaki

    2 min read6 chapters

    Detailed Narrative

    01

    Q4 and FY25 Financial Performance Overview

    Honasa Consumer reported a healthy double-digit growth of 13.3% in Q4 FY25, with a strong Underlying Volume Growth (UVG) of 21.2%. For the full fiscal year FY25, the company achieved INR2,067 crores in revenue, representing a 7.7% growth. Gross profit improved year-over-year, and EBITDA remained stable in Q4. The company also generated INR74 crores of cash in Q4, reflecting a negative 24 days working capital, although full-year profit was impacted by 'project Neev' execution and corrections.

    02

    Mamaearth's Strategic Shift and Performance

    Mamaearth, the core brand, has shifted its focus to key categories like facewash, shampoo, sunscreen, moisturizer, and baby products, which now contribute 70% to the brand's revenue. These focus categories demonstrated positive double-digit growth in Q4 in e-commerce and modern trade channels. The company aims to increase the contribution of these focus categories to 85-90% of Mamaearth's revenue over the next 2-3 years, while tactically managing non-focus categories to reduce their contribution from 30% to 15%.

    03

    Distribution System Enhancements and Offline Growth

    The company successfully transitioned its direct distribution system, increasing direct distributor contribution from 38% to 71%. The direct distribution network expanded significantly, reaching 102,000 outlets, up from 45,000-50,000. This improved system is benefiting other brands like Derma Co, which achieved INR100 crores Annual Run Rate (ARR) in offline channels (GT plus MT) in March. The target is to further expand GT direct distribution to 150,000 outlets over the next 12 months.

    04

    Younger Brands and Innovation Focus

    Honasa's younger brands collectively grew over 30% year-over-year in FY25. The company continues to prioritize innovation, particularly in prestige categories, with first-to-India launches like micronedle-based serum shots and Vitamic C-based ampoule kits by Derma Co, and Pdrn as an active by Dr. Sheth's. R&D capabilities have been strengthened through the acquisition of Cosmogenesis, leading to product improvements like enhanced serum penetration and gel face washes outperforming market leaders in blind tests.

    05

    AI Integration and Future Outlook

    The company is actively integrating AI into its operations, with a dedicated team working on agentic workflows to enhance efficiency across marketing, supply chain, and finance. Examples include AI-powered skin analyzers, purchase assistants, and content generation. Management believes AI will significantly improve effectiveness and efficiency, with a focus on building internal AI tools this year. The overall strategy is now focused on execution, with management bandwidth fully dedicated to achieving growth targets.

    06

    A&P Spend and Margin Strategy

    Management views A&P spend as a bucket for potential leverage and aims to drive effectiveness to reduce it as a percentage of revenue over the years, contributing to EBITDA improvement. While younger brands currently require higher A&P spend due to lower awareness, the company expects overall EBITDA profile to return to FY24 levels by exit, with a significant improvement of 250 basis points over FY25.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.